Indication*

Injection: Omeprazole is indicated for the treatment of duodenal ulcer, gastric ulcer, reflux oesophagitis and in control of acid secretion in pathological hypersecretory conditions, e.g.,Zollinger-Ellison syndrome.

Directions for Use*

Injection: Patients who are unable to take oral medication, e.g. in severely ill patients with either reflux oesophagitis, duodenal ulcer or gastric ulcer: Omeprazole 40 mg, can be given as IV bolus or infusion once daily for up to 5 days. Zollinger-Ellison syndrome: Initially 60mg IV daily, then adjust dose individually. For doses exceeding 60mg daily, given as divided doses twice daily. Administration: by intravenous route only and not by any other route. Use in Children: The safety and effectiveness of omeprazole sodium injection in children is not established. Use in Elderly Patients: It is not necessary to adjust the dose of omeprazole in elderly patients. However, a slight decrease in elimination rate and an increase in bioavailability are likely to occur in such patients. Use in Patients with Impaired Liver Function: Bioavailability and half-life of Omeprazole can increase in patients with hepatic impairment. UK licensed product information recommends that a maximum daily oral dose of 20 mg be used in these patients; a daily intravenous dose of 10 to 20mg is considered sufficient.

Administration*

Should be taken with food: Take immediately before a meal.

*written indications, directions, and administration are updated as of April 21, 2024 and may not be accurate with the actual product purchased. Please read the details in the packaging.